Infectious Disease & Vaccines

Scientists developed a gel formulation that makes swallowing medicines easier. 

Microarray, or microneedle, patches could boost vaccine access in low- and middle-income countries.

Bacteria can stop a viral infection by an act of altruistic suicide.

Bacterial contaminants in cell cultures pose a significant threat to the biopharmaceutical safety. How do scientists detect these hard-to-spot pests?

Mice vaccinated with spirulina expressing a malaria parasite protein were protected from infection, setting the stage for future clinical trials.

The unique life cycles of bacteria in the gut of a parasitic worm and its prey make for an unexpected but prolific source of new antibiotics.

What do zoonotic spillover events reveal about virus-host biology and how do scientists use these lessons to inform future mitigation strategies? 

Detecting virus-specific genes enables the differentiation of multiple respiratory infections. 

Advances in computation and artificial intelligence help scientists identify novel antibiotics encoded within human proteins and create new ones.

Researchers investigate new approaches to revolutionizing vaccines for cancer and infectious diseases. 

Mycologists programmed immune cells to attack Aspergillus fumigatus, a common infectious species rapidly growing resistant to antifungals.

Researchers seeking new classes of chemical compounds or pursuing alternative antibacterial approaches make their cases.